{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:15:59Z","timestamp":1773278159988,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J05291"],"award-info":[{"award-number":["2023J05291"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100215"],"award-info":[{"award-number":["82100215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["22ZR1411400"],"award-info":[{"award-number":["22ZR1411400"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genes &amp; Diseases"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.gendis.2024.101214","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T10:03:38Z","timestamp":1705485818000},"page":"101214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner"],"prefix":"10.1016","volume":"12","author":[{"given":"Jiadai","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panpan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9639-6606","authenticated-orcid":false,"given":"Peng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.gendis.2024.101214_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/jama.2021.25306","article-title":"What is multiple myeloma?","volume":"327","author":"Silberstein","year":"2022","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.gendis.2024.101214_bib2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3390\/cells10020336","article-title":"Genetic abnormalities in multiple myeloma: prognostic and therapeutic implications","volume":"10","author":"Cardona-Benavides","year":"2021","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.gendis.2024.101214_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41408-021-00474-8","article-title":"Chromosome 1q21 abnormalities in multiple myeloma","volume":"11","author":"Schmidt","year":"2021","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.gendis.2024.101214_bib4","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41580-023-00654-3","article-title":"Publisher Correction: Reading, writing and erasing mRNA methylation","volume":"24","author":"Zaccara","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.gendis.2024.101214_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/s41388-021-02095-8","article-title":"RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-\u03baB and MAPK signaling pathways","volume":"41","author":"Qu","year":"2022","journal-title":"Oncogene"},{"issue":"35","key":"10.1016\/j.gendis.2024.101214_bib6","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1038\/s41388-021-01939-7","article-title":"IDH2 contributes to tumorigenesis and poor prognosis by regulating m6A RNA methylation in multiple myeloma","volume":"40","author":"Song","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib7","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13045-021-01066-6","article-title":"HNRNPA2B1 promotes multiple myeloma progression by increasing AKT3 expression via m6A-dependent stabilization of ILF3 mRNA","volume":"14","author":"Jiang","year":"2021","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/BC20040151","article-title":"VICKZ proteins: a multi-talented family of regulatory RNA-binding proteins","volume":"97","author":"Yisraeli","year":"2005","journal-title":"Biol Cell"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1074\/jbc.M114.614735","article-title":"Molecular insights into the coding region determinant-binding protein-RNA interaction through site-directed mutagenesis in the heterogeneous nuclear ribonucleoprotein-K-homology domains","volume":"290","author":"Barnes","year":"2015","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.gendis.2024.101214_bib10","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.gendis.2023.06.017","article-title":"IGF2BPs as novel m6A readers: diverse roles in regulating cancer cell biological functions, hypoxia adaptation, metabolism, and immunosuppressive tumor microenvironment","volume":"11","author":"Duan","year":"2023","journal-title":"Genes Dis"},{"issue":"3","key":"10.1016\/j.gendis.2024.101214_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10.1016\/j.gendis.2024.101214_bib12","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/nar\/gkl1148","article-title":"CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease","volume":"35","author":"Sparanese","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"7095","key":"10.1016\/j.gendis.2024.101214_bib13","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/nature04839","article-title":"CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling","volume":"441","author":"Noubissi","year":"2006","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.gendis.2024.101214_bib14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.molcel.2009.06.007","article-title":"CRD-BP protects the coding region of betaTrCP1 mRNA from miR-183-mediated degradation","volume":"35","author":"Elcheva","year":"2009","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.gendis.2024.101214_bib15","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1093\/carcin\/bgt217","article-title":"IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts","volume":"34","author":"Hamilton","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1158\/0008-5472.CAN-03-2927","article-title":"Mammary tumor induction in transgenic mice expressing an RNA-binding protein","volume":"64","author":"Tessier","year":"2004","journal-title":"Cancer Res"},{"issue":"5","key":"10.1016\/j.gendis.2024.101214_bib17","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.tranon.2017.07.008","article-title":"A novel IMP1 inhibitor, BTYNB, targets c-myc and inhibits melanoma and ovarian cancer cell proliferation","volume":"10","author":"Mahapatra","year":"2017","journal-title":"Transl Oncol"},{"key":"10.1016\/j.gendis.2024.101214_bib18","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","article-title":"The multiple myelomas \u2014 current concepts in cytogenetic classification and therapy","volume":"15","author":"Kumar","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101214_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.gendis.2024.101214_bib20","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.3389\/fimmu.2020.01292","article-title":"Globular C1q receptor (gC1qR\/p32\/HABP1) suppresses the tumor-inhibiting role of C1q and promotes tumor proliferation in 1q21-amplified multiple myeloma","volume":"11","author":"Xu","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.gendis.2024.101214_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/leu.2011.357","article-title":"Dysregulation of TNF\u03b1-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1","volume":"26","author":"Liu","year":"2012","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.gendis.2024.101214_bib22","first-page":"574","article-title":"Chidamide, a novel histone deacetylase inhibitor, inhibits multiple myeloma cells proliferation through succinate dehydrogenase subunit A","volume":"9","author":"Sun","year":"2019","journal-title":"Am J Cancer Res"},{"issue":"15","key":"10.1016\/j.gendis.2024.101214_bib23","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"issue":"4","key":"10.1016\/j.gendis.2024.101214_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.3317","article-title":"HISAT: a fast spliced aligner with low memory requirements","volume":"12","author":"Kim","year":"2015","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.gendis.2024.101214_bib25","doi-asserted-by":"crossref","first-page":"R22","DOI":"10.1186\/gb-2011-12-3-r22","article-title":"Improving RNA-Seq expression estimates by correcting for fragment bias","volume":"12","author":"Roberts","year":"2011","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/j.gendis.2024.101214_bib26","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101214_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1109\/TCBB.2015.2403355","article-title":"MeTDiff: a novel differential RNA methylation analysis for MeRIP-seq data","volume":"15","author":"Cui","year":"2018","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"7481","key":"10.1016\/j.gendis.2024.101214_bib28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.gendis.2024.101214_bib29","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1242\/jcs.210682","article-title":"Publisher\u2019s Note: Chromosomal breaks during mitotic catastrophe trigger \u03b3H2AX-ATM-p53-mediated apoptosis. J. Cell Sci","volume":"130","author":"Imreh","year":"2017","journal-title":"J Cell Sci"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-02503-9","article-title":"The effect of paclitaxel on apoptosis, autophagy and mitotic catastrophe in AGS cells","volume":"11","author":"Khing","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.gendis.2024.101214_bib31","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1093\/nar\/gkw104","article-title":"SRAMP: prediction of mammalian N6-methyladenosine (m6A) sites based on sequence-derived features","volume":"44","author":"Zhou","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"Pt 24","key":"10.1016\/j.gendis.2024.101214_bib32","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1242\/jcs.113.24.4523","article-title":"Human Cdc5, a regulator of mitotic entry, can act as a site-specific DNA binding protein","volume":"113","author":"Lei","year":"2000","journal-title":"J Cell Sci"},{"issue":"9","key":"10.1016\/j.gendis.2024.101214_bib33","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/embor.2009.122","article-title":"Cdc5L interacts with ATR and is required for the S-phase cell-cycle checkpoint","volume":"10","author":"Zhang","year":"2009","journal-title":"EMBO Rep"},{"issue":"15","key":"10.1016\/j.gendis.2024.101214_bib34","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1093\/nar\/gkaa653","article-title":"The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer","volume":"48","author":"M\u00fcller","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.gendis.2024.101214_bib35","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/hep.26997","article-title":"Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma","volume":"59","author":"Gutschner","year":"2014","journal-title":"Hepatology"},{"issue":"54","key":"10.1016\/j.gendis.2024.101214_bib36","doi-asserted-by":"crossref","first-page":"7584","DOI":"10.1038\/sj.onc.1210563","article-title":"Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma","volume":"26","author":"K\u00f6bel","year":"2007","journal-title":"Oncogene"},{"issue":"31","key":"10.1016\/j.gendis.2024.101214_bib37","doi-asserted-by":"crossref","first-page":"31134","DOI":"10.18632\/oncotarget.5290","article-title":"HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide","volume":"6","author":"Canella","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1261\/rna.1175909","article-title":"Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs","volume":"15","author":"Weidensdorfer","year":"2009","journal-title":"RNA"},{"issue":"5","key":"10.1016\/j.gendis.2024.101214_bib39","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1158\/0008-5472.CAN-13-2020","article-title":"Differential regulation of estrogen receptor \u03b1 expression in breast cancer cells by metastasis-associated protein 1","volume":"74","author":"Kang","year":"2014","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/nar\/gkt844","article-title":"siRNA enhances DNA-mediated interferon lambda-1 response through crosstalk between RIG-I and IFI16 signalling pathway","volume":"42","author":"Sui","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.gendis.2024.101214_bib41","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/s41397-021-00230-y","article-title":"Increased expression of IFI16 predicts adverse prognosis in multiple myeloma","volume":"21","author":"Huang","year":"2021","journal-title":"Pharmacogenomics J"},{"issue":"12","key":"10.1016\/j.gendis.2024.101214_bib42","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3390\/cancers13123017","article-title":"Prognostic significance of KIF11 and KIF14 expression in pancreatic adenocarcinoma","volume":"13","author":"Klimaszewska-Wi\u015bniewska","year":"2021","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.gendis.2024.101214_bib43","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/ijc.26189","article-title":"Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer","volume":"130","author":"Th\u00e9riault","year":"2012","journal-title":"Int J Cancer"},{"issue":"19","key":"10.1016\/j.gendis.2024.101214_bib44","doi-asserted-by":"crossref","first-page":"8013","DOI":"10.18632\/aging.204332","article-title":"Noncoding RNAs-mediated overexpression of KIF14 is associated with tumor immune infiltration and unfavorable prognosis in lung adenocarcinoma","volume":"14","author":"Wang","year":"2022","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib45","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1038\/s41467-021-23581-3","article-title":"Structural basis of mechano-chemical coupling by the mitotic kinesin KIF14","volume":"12","author":"Benoit","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.gendis.2024.101214_bib46","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1179\/1607845413Y.0000000125","article-title":"The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes","volume":"19","author":"Cohen","year":"2014","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.gendis.2024.101214_bib47","doi-asserted-by":"crossref","first-page":"4093","DOI":"10.1007\/s13277-015-4088-5","article-title":"Expression of CDC5L is associated with tumor progression in gliomas","volume":"37","author":"Chen","year":"2016","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.gendis.2024.101214_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/leu.2013.247","article-title":"IMWG consensus on risk stratification in multiple myeloma","volume":"28","author":"Chng","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.gendis.2024.101214_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7150\/jca.32850","article-title":"Depletion of CDC5L inhibits bladder cancer tumorigenesis","volume":"11","author":"Zhang","year":"2020","journal-title":"J Cancer"},{"issue":"11","key":"10.1016\/j.gendis.2024.101214_bib50","doi-asserted-by":"crossref","first-page":"11100","DOI":"10.18632\/aging.103326","article-title":"ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L","volume":"12","author":"Liu","year":"2020","journal-title":"Aging"},{"issue":"23","key":"10.1016\/j.gendis.2024.101214_bib51","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1093\/emboj\/19.23.6569","article-title":"Functional analysis of the human CDC5L complex and identification of its components by mass spectrometry","volume":"19","author":"Ajuh","year":"2000","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.gendis.2024.101214_bib52","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cub.2006.04.043","article-title":"Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint","volume":"16","author":"Brito","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.gendis.2024.101214_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13887","article-title":"Profiling DNA damage response following mitotic perturbations","volume":"7","author":"Pedersen","year":"2016","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.gendis.2024.101214_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s42003-021-01979-5","article-title":"Multinucleation associated DNA damage blocks proliferation in p53-compromised cells","volume":"4","author":"Hart","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.gendis.2024.101214_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.608816","article-title":"Inhibition of the mRNA-binding protein IGF2BP1 suppresses proliferation and sensitizes neuroblastoma cells to chemotherapeutic agents","volume":"11","author":"Biegel","year":"2021","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.gendis.2024.101214_bib56","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.3390\/cancers14092121","article-title":"IGF2BP1 promotes proliferation of neuroendocrine neoplasms by post-transcriptional enhancement of EZH2","volume":"14","author":"Sperling","year":"2022","journal-title":"Cancers"}],"container-title":["Genes &amp; Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224000114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352304224000114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T11:36:33Z","timestamp":1731411393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352304224000114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":56,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2352304224000114"],"URL":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101214","relation":{},"ISSN":["2352-3042"],"issn-type":[{"value":"2352-3042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF2BP1 promotes multiple myeloma with chromosome 1q gain via increasing CDC5L expression in an m6A-dependent manner","name":"articletitle","label":"Article Title"},{"value":"Genes & Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gendis.2024.101214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101214"}}